NCAN and metabolic dysfunction-associated steatotic liver disease: To further evaluate whether shared causal variants underlie both protein expression and disease phenotypes, Bayesian colocalization analysis was employed, ultimately confirming NCAN as a likely pathogenic factor for MASLD.